Comparison of breathing acoustic characteristics in patients with asthma and healthy volunteers Source: Eur Respir J 2005; 26: Suppl. 49, 118s Year: 2005
Lung deposition of formoterol HFA in healthy volunteers, asthmatic and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005
Development of an exhaled breath protein pattern to distinguish asthmatic from healthy children Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Comparison of balance and coordination abilities between asthmatic patients and healthy subjects> Source: International Congress 2018 – Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions Year: 2018
Comparison of pulmonary and systemic absoption of two HFA formulations of salmeterol in healthy subjects Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
Baseline inflammation in the lower airways of allergic rhinitic subjects compared to normal subjects Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001
Comparison of aerosol deposition pattern in healthy subjects: 3D SPECT measurements vs simulation results Source: Annual Congress 2012 - Standard of care, incidential findings, image acquisition Year: 2012
Salmeterol has no effect on increased bronchial responsiveness induced by organic dust exposure in healthy volunteers Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Systemic and airways inflammation in healthy subjects and COPD patients of different ages Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007
Repeatibility of eNO measurements in asthmatic and healthy children Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma Year: 2003
Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 338s Year: 2004
Aerosol deposition in asthmatic subjects breathing helium-oxygen vs. air Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Aminoguanidine inhibits bronchial NO production, but not diffusion or alveolar NO in patients with asthma, smokers and healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
Airway responsiveness in healthy subjects following exposure to ammonia Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Ozone induced bronchial epithelial cytokine expression differs between asthmatic and healthy subjects Source: Eur Respir J 2002; 20: Suppl. 38, 22s Year: 2002
Systemic and airways‘ inflammation in healthy subjects of different ages Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Allergic inflammation in serum and sputum: comparison between healthy controls and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 393s Year: 2004
Late Breaking Abstract - Day-to-day variability in exhaled breath profiles of asthmatic patients and healthy volunteers challenged with a rhinovirus Source: International Congress 2019 – Basic research of airway diseases Year: 2019
Bronchodilator response in healthy subjects Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020
Comparison between the endurance of respiratory muscles in the normal environment and in water for healthy and asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 730s Year: 2006